Abstract
Purpose
To investigate the effects of chronotherapy on blood pressure in patients with chronic kidney disease (CKD).
Methods
We searched PUBMED, EMBASE, ASN-ONLINE, the Cochrane Library and the reference articles of published papers without language restriction, for randomized and non-randomized trials that assessed the effect of chronotherapy versus morning dosing regimen drug therapy for CKD patients with hypertension. Meta-analysis was done with random-effect models.
Results
After application of inclusion/exclusion criteria, three randomized controlled trials including 3380 patients were analyzed. Compared with morning dosing regimen drug therapy, chronotherapy was associated with a significant decrease of 3.55% in sleep-time relative decline of systolic blood pressure (SBP) (mean difference [MD], 95% CI, [0.22, 6.88]). In the chronotherapy group, we noted a significant decrease in nocturnal SBP (MD −3.79 mmHg, 95% CI, [−7.18, −0.41]) and nocturnal diastolic blood pressure (MD −1.55 mmHg, 95% CI. [− 2.28, −0.82]), but there was a small increase in awake SBP by 1.19 mmHg (MD, 95% CI, [0.06, 2.31]). No significant difference was noted in all-cause mortality and cardiovascular mortality.
Conclusion
This meta-analysis suggests that chronotherapy could reduce nocturnal BP in hypertensive CKD patients.
Similar content being viewed by others
References
Townsend RR, Taler SJ (2015) Management of hypertension in chronic kidney disease. Nat Rev Nephrol 11(9):555–563. doi:10.1038/nrneph.2015.114
Ritz E, Bakris G (2009) World kidney day: hypertension and chronic kidney disease. Lancet 373(9670):1157–1158. doi:10.1016/S0140-6736(09)60355-X
Torbjornsdotter TB, Jaremko GA, Berg UB (2004) Nondipping and its relation to glomerulopathy and hyperfiltration in adolescents with type 1 diabetes. Diabetes Care 27(2):510–516
Basile JN, Bloch MJ (2013) Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease. J Clin Hypertens (Greenwich, Conn) 15(1):2–4. doi:10.1111/jch.12028
Davidson MB, Hix JK, Vidt DG, Brotman DJ (2006) Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 166(8):846–852. doi:10.1001/archinte.166.8.846
Zhao P, Xu P, Wan C, Wang Z (2011) Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. doi:10.1002/14651858.CD004184.pub2
Smolensky MH (1996) Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens 9(4 Pt 3):11S–21S
Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Maeda A, Dejima T, Wakui H, Ozawa M, Shigenaga A, Toya Y, Umemura S (2011) Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease. Am J Cardiovasc Disease 1(3):236–243
Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H (2014) Evening-versus morning-dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review. Kidney Blood Press Res 39(5):427–440. doi:10.1159/000368456
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34. doi:10.1016/j.jclinepi.2009.06.006
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
Van Tulder M, Furlan A, Bombardier C, Bouter L (2003) Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 28(12):1290–1299. doi:10.1097/01.BRS.0000065484.95996.AF
Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions, version 5.0.2. The Cochrane Collaboration and John Wiley & Sons, Chichester, West Sussex
Crespo JJ, Pineiro L, Otero A, Castineira C, Rios MT, Regueiro A, Mojon A, Lorenzo S, Ayala DE, Hermida RC (2013) Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol Int 30(1–2):159–175. doi:10.3109/07420528.2012.701459
Hermida RC, Ayala DE, Mojon A, Fernandez JR (2011) Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol: JASN 22(12):2313–2321. doi:10.1681/ASN.2011040361
Wang C, Zhang J, Liu X, Li CC, Ye ZC, Peng H, Chen Z, Lou T (2013) Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens (Greenwich, Conn) 15(1):48–54. doi:10.1111/jch.12021
Vogt L, Van DEA, Navis GJ, De DZ, Hemmelder HM (2010) Optimal dosing time for the long-acting ace inhibitor trandolapril in non-diabetic kidney disease. J Hypertens 28:e387
Hermida RC, Ayala DE, Smolensky MH, Portaluppi F (2007) Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation. Expert Rev Cardiovasc Ther 5(3):463–475. doi:10.1586/14779072.5.3.463
Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F (2010) Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit 15(4):173–180. doi:10.1097/MBP.0b013e32833c7308
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990) Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335(8693):827–838
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335(8692):765–774
Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46(1):156–161. doi:10.1161/01.HYP.0000170138.56903.7a
Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA 282(6):539–546
Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA (2009) Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53(1):20–27. doi:10.1161/hypertensionaha.108.115154
Hermida RC, Calvo C, Ayala DE, Lopez JE (2005) Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 46(4):960–968. doi:10.1161/01.HYP.0000174616.36290.fa
Acknowledgements
This study was supported by the National Natural Science Foundation of China (Grant Nos. 81370866 and 81070612), the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant Nos. 2011B031800084 and 2013B021800190), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38) and the National Project of Scientific and Technical Supporting Programs funded by Ministry of Science and Technology of China (Grant No. 2011BAI10B00).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Caixia Wang, Xilian Qiu and Linsheng Lv have contributed equally to the paper.
Xun Liu and Tanqi Lou have contributed equally to the paper.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, C., Qiu, X., Lv, L. et al. Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients. Int Urol Nephrol 49, 651–659 (2017). https://doi.org/10.1007/s11255-016-1437-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1437-2